RESUMEN

La coagulación de la sangre suscita un interés multidisciplinar incrementado. La cirugía cardiaca produce cambios importantes en el delicado equilibrio entre los factores séricos pro- y anticoagulantes. El papel de la antitrombina iii se ha analizado después de conocer evidencias que relacionan bajos niveles de actividad de la proteína con la morbimortalidad postoperatoria. El aporte exógeno de antitrombina se considera con objeto de optimizar los resultados posquirúrgicos. Sus propiedades anticoagulante y antiinflamatoria intrínsecas despiertan un creciente interés y sugieren nuevas líneas de investigación (AU)

---

Coagulation of blood is of multidisciplinary interest. Cardiac surgery produces major changes in the delicate balance between pro-and anti-coagulant serum factors. The role of antithrombin iii has been analysed after finding evidence that associated decreased levels of protein activity to postoperative morbidity and mortality. Supplementing exogenous antithrombin is considered with the aim of optimising outcomes. Its intrinsic anticoagulant and anti-inflammatory properties have stimulated a growing interest, and suggests new lines of research (AU)

Asunto(s)

Humanos , Masculino , Femenino , Antitrombina III/administración & dosificación , Antitrombina III/uso terapéutico , Cirugía Torácica/métodos , Cirugía Torácica/tendencias , Coagulación Sanguínea , Epoprostenol/uso terapéutico , Circulación Extracorporea/métodos , Antitrombina III/metabolismo , Antitrombina III/farmacocinética , Cirugía Torácica/organización & administración , Cirugía Torácica/normas , Trastornos de la Coagulación Sanguínea/complicaciones , Trastornos de la Coagulación Sanguínea/tratamiento farmacológico , Deficiencia de Antitrombina III/complicaciones , Modelos Lineales

RESUMEN

We analyzed the kinetic and spatial patterns characterizing activation of the MAP kinases ERK 1 and 2 (ERK1/2) by the three α1-adrenoceptor (α1-AR) subtypes in HEK293 cells and the contribution of two different pathways to ERK1/2 phosphorylation: protein kinase C (PKC)-dependent ERK1/2 activation and internalization-dependent ERK1/2 activation. The different pathways of phenylephrine induced ERK phosphorylation were determined by western blot, using the PKC inhibitor Ro 31-8425, the receptor internalization inhibitor concanavalin A and the siRNA targeting ß-arrestin 2. Receptor internalization properties were studied using CypHer5 technology and VSV-G epitope-tagged receptors. Activation of α1A- and α1B-ARs by phenylephrine elicited rapid ERK1/2 phosphorylation that was directed to the nucleus and inhibited by Ro 31-8425. Concomitant with phenylephrine induced receptor internalization α1A-AR, but not α1B-AR, produced a maintained and PKC-independent ERK phosphorylation, which was restricted to the cytosol and inhibited by ß-arrestin 2 knockdown or concanavalin A treatment. α1D-AR displayed constitutive ERK phosphorylation, which was reduced by incubation with prazosin or the selective α1D antagonist BMY7378. Following activation by phenylephrine, α1D-AR elicited rapid, transient ERK1/2 phosphorylation that was restricted to the cytosol and not inhibited by Ro 31-8425. Internalization of the α1D-AR subtype was not observed via CypHer5 technology. The three α1-AR subtypes present different spatio-temporal patterns of receptor internalization, and only α1A-AR stimulation translates to a late, sustained ERK1/2 phosphorylation that is restricted to the cytosol and dependent on ß-arrestin 2 mediated internalization.

Asunto(s)

Endocitosis/fisiología , Proteína Quinasa 1 Activada por Mitógenos/metabolismo , Proteína Quinasa 3 Activada por Mitógenos/metabolismo , Receptores Adrenérgicos alfa 1/metabolismo , Arrestinas/antagonistas & inhibidores , Arrestinas/genética , Arrestinas/metabolismo , Western Blotting , Células Cultivadas , Concanavalina A/farmacología , Endocitosis/efectos de los fármacos , Inhibidores Enzimáticos/farmacología , Humanos , Técnicas para Inmunoenzimas , Riñón/citología , Riñón/metabolismo , Proteína Quinasa 1 Activada por Mitógenos/genética , Proteína Quinasa 3 Activada por Mitógenos/genética , Fosforilación , Proteína Quinasa C/antagonistas & inhibidores , Proteína Quinasa C/metabolismo , ARN Mensajero/genética , ARN Interferente Pequeño/genética , Reacción en Cadena en Tiempo Real de la Polimerasa , Receptores Adrenérgicos alfa 1/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Transducción de Señal , Arrestina beta 2 , beta-Arrestinas

RESUMEN

Coagulation of blood is of multidisciplinary interest. Cardiac surgery produces major changes in the delicate balance between pro-and anti-coagulant serum factors. The role of antithrombin iii has been analysed after finding evidence that associated decreased levels of protein activity to postoperative morbidity and mortality. Supplementing exogenous antithrombin is considered with the aim of optimising outcomes. Its intrinsic anticoagulant and anti-inflammatory properties have stimulated a growing interest, and suggests new lines of research.

Asunto(s)

Antitrombina III/fisiología , Procedimientos Quirúrgicos Cardíacos , Antitrombina III/análisis , Antitrombina III/uso terapéutico , Deficiencia de Antitrombina III/tratamiento farmacológico , Deficiencia de Antitrombina III/etiología , Deficiencia de Antitrombina III/mortalidad , Circulación Extracorporea/efectos adversos , Humanos , Síndrome de Respuesta Inflamatoria Sistémica/etiología

RESUMEN

Expression of the neurotrophin receptor trkB is regulated by thyroid hormone (T3) during development of the rat brain. trkB mRNA levels, coding for the full-length and the truncated isoforms, are increased in the cerebral cortex of neonatal experimental hypothyroid animals. Run-on transcription assays with nuclei from postnatal day 15, hypothyroid, and control cerebral cortices demonstrated that an increase in the transcription rate of the trkB gene accounts for the observed effect. Transient transfection experiments using a reporter plasmid containing a 7-kilobase pair DNA fragment upstream of the mouse trkB gene showed that unliganded thyroid hormone receptor (T3R) increases promoter activity, whereas addition of T3 reverses that activity below basal levels. Deletion analysis shows that the T3-dependent repression requires binding of the T3R to a specific region located downstream of the transcription start site. This region, at nucleotide position -465/-432, contains an array of thyroid hormone response half-sites that bind preferentially T3R as heterodimers with retinoid X receptor and whose deletion causes loss of the T3-dependent repression. These half-sites are able to confer negative regulation by T3 to a heterologous promoter, thus indicating the functionality of these sequences. These results demonstrate that, in the developing rat brain, T3 down-regulates the expression of the trkB gene through the active repression of a novel negative response element located downstream of its transcription initiation site.

Asunto(s)

Encéfalo/metabolismo , Regulación de la Expresión Génica/fisiología , Receptor trkB/genética , Transcripción Genética , Triyodotironina/fisiología , Animales , Secuencia de Bases , Encéfalo/embriología , Hipotiroidismo/genética , Datos de Secuencia Molecular , ARN Mensajero/genética , Ratas , Ratas Wistar , Eliminación de Secuencia

RESUMEN

Neural cell adhesion molecules (NCAMs) play critical roles during development of the nervous system. The aim of this study is to investigate the possible effect of ethanol exposure on the pattern of expression and sialylation of NCAM isoforms during postnatal rat brain development because alterations in NCAM content and distribution have been associated with defects in cell migration, synapse formation, and memory consolidation, and deficits in these processes have been observed after in utero alcohol exposure. The expression of NCAM isoforms in the developing cerebral cortex of pups from control and alcohol-fed mothers was assessed by western blotting, ribonuclease protection assay, and immunocytochemistry. The highly sialylated form of NCAM [polysialic acid (PSA)-NCAM] is mainly expressed during the neonatal period and then is down-regulated in parallel with the appearance of NCAM 180 and NCAM 140. Ethanol exposure increases PSA-NCAM levels during the neonatal period, delays the loss of PSA-NCAM, decreases the amount of NCAM 180 and NCAM 140 isoforms, and reduces sialyltransferase activity during postnatal brain development. Neuraminidase treatment of ethanol-exposed neonatal brains leads to more intense band degradation products, suggesting a higher content of NCAM polypeptides carrying PSA in these samples. However, NCAM mRNA levels are not changed by ethanol. Immunocytochemical analysis demonstrates that ethanol triggers an increase in PSA-NCAM immunolabeling in the cytoplasm of astroglial cells, accompanied by a decrease in immunogold particles over the plasma membrane. These findings indicate that ethanol exposure during brain development alters the pattern of NCAM expression and suggest that modification of NCAM could affect neuronal-glial interactions that might contribute to the brain defects observed after in utero alcohol exposure.

Asunto(s)

Envejecimiento/metabolismo , Alcoholismo/fisiopatología , Corteza Cerebral/metabolismo , Regulación del Desarrollo de la Expresión Génica , Molécula L1 de Adhesión de Célula Nerviosa , Moléculas de Adhesión de Célula Nerviosa/genética , Efectos Tardíos de la Exposición Prenatal , Animales , Corteza Cerebral/crecimiento & desarrollo , Femenino , Inmunohistoquímica , Lactancia , Moléculas de Adhesión de Célula Nerviosa/análisis , Neuraminidasa , Embarazo , Isoformas de Proteínas/análisis , Isoformas de Proteínas/genética , Ratas , Ratas Wistar , Ácidos Siálicos/análisis , Ácidos Siálicos/genética , Transcripción Genética

RESUMEN

Although cultured astroglial cells were reported to express exclusively the truncated non-catalytic Trk B receptor for brain-derived neurotrophic factor (BDNF), we detect here, using a sensitive ribonuclease protection assay, mRNAs for both truncated (TrkB-T) and the full length catalytic (TrkB-fl) form of BDNF receptor in developing cortical astrocytes and neurons in culture. Cortical neurons and immature astroglia, such as radial glia and proliferating astrocytes, express both the protein and mRNAs for TrkB-fl and TrkB-T, whereas the differentiation of astrocytes leads to a decrease in the trkB-fl mRNA, being the truncated TrkB the predominant receptor in differentiating and confluent astrocytes. The levels of TrkB-fl expression in proliferating and differentiating astrocytes and neurons correlates with the cell response to BDNF, monitored by the rise in intracellular [Ca(2+)](i). Foetal exposure to ethanol alters astroglial development and delays the reduction in trkB-fl mRNA levels observed with differentiation of astrocytes. These results demonstrate that immature astrocytes are able to express the catalytic Trk B receptors and to respond to BDNF with the activation of conventional signal transduction pathways. The results suggest that this signalling pathway is more activated in ethanol-exposed cells.

Asunto(s)

Astrocitos/efectos de los fármacos , Factor Neurotrófico Derivado del Encéfalo/farmacología , Calcio/metabolismo , Depresores del Sistema Nervioso Central/toxicidad , Etanol/toxicidad , Receptor trkB/genética , Animales , Astrocitos/citología , Astrocitos/metabolismo , Diferenciación Celular/efectos de los fármacos , Células Cultivadas , Feto/citología , Regulación del Desarrollo de la Expresión Génica/efectos de los fármacos , ARN Mensajero/análisis , Ratas

RESUMEN

We have analysed a 7-kb region upstream of the mouse trkB coding sequence. The region showed promoter activity in transient transfection experiments and conferred tissue-specific expression to a reporter gene. Deletion analysis of this region demonstrated the presence of two alternative promoters named P1 and P2 that have been mapped by RNase protection. P1 has been located to 1.8 kb and P2 to 0.5 kb upstream of the trkB translation start site. From the P1 promoter, alternative splicing generates various transcripts. Interestingly, P2 is located in an intron of the transcripts produced from the P1 promoter. This peculiar arrangement results in different mRNA species that encode the same protein(s) but differ in their 5'-untranslated regions. In addition, transcription of the trkB locus results in two different trkB isoforms (kinase and truncated receptors) originated by alternative splicing of the mRNA, that possess differential spatial and temporal expression patterns. Using RT-PCR, we demonstrated that there was no linkage between promoter usage and alternative splicing, since transcripts initiated from each promoter encoded both kinase and truncated receptor proteins.

Asunto(s)

Regiones Promotoras Genéticas , Proteínas Tirosina Quinasas Receptoras/genética , Receptores de Factor de Crecimiento Nervioso/genética , Animales , Secuencia de Bases , ADN/química , Regulación de la Expresión Génica , Ratones , Datos de Secuencia Molecular , Receptor de Factor Neurotrófico Ciliar , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Transcripción Genética

Asunto(s)

Diabetes Mellitus Tipo 2/tratamiento farmacológico , Diabetes Mellitus/tratamiento farmacológico , Hipoglucemiantes/uso terapéutico , Obesidad , Tiazoles/uso terapéutico , Diabetes Mellitus/metabolismo , Diabetes Mellitus Tipo 2/metabolismo , Humanos , Hipoglucemiantes/farmacocinética , Hipoglucemiantes/farmacología , Receptores Citoplasmáticos y Nucleares/metabolismo , Tiazoles/farmacocinética , Tiazoles/farmacología , Factores de Transcripción/metabolismo

RESUMEN

Thyroid hormone plays an important role in brain development, in part by regulating myelination. Previous studies have shown that the myelin basic protein (MBP) promoter is activated by thyroid hormone (T3) via a T3-response element (T3RE) at position -186. Surprisingly, although MBP levels are initially decreased in hypothyroid neonates, they approach later control levels, in most brain regions, despite persistent hypothyroidism. We have studied the T3-independent transcriptional regulation of this gene, using transient transfection assays. We found that, in the absence of T3, the RXR ligand, 9-cis-retinoic acid (9cRA) was able to stimulate transcription of the MBP promoter in a dose-dependent manner. This activation was unaffected by the mutation or deletion of the T3RE and required DNA sequences located between positions -162/+60. Accordingly, this MBP promoter fragment bound RXR in vitro. The 9cRA-dependent activation of the MBP promoter required the presence of both, the DNA binding and the ligand-dependent transactivation domain (AF-2) in RXR. Furthermore, as T3, 9cRA was able to stimulate MBP expression in the CG-4 cell line after differentiation to oligodendrocytes and increased the number of cells expressing the MBP protein in primary rat optic nerve glial cell cultures.

Asunto(s)

Proteína Básica de Mielina/genética , Regiones Promotoras Genéticas/efectos de los fármacos , Tretinoina/farmacología , Triyodotironina/farmacología , Alitretinoína , Animales , Sitios de Unión/fisiología , Células Cultivadas , Regulación de la Expresión Génica/efectos de los fármacos , Operón Lac , Proteína Básica de Mielina/química , Vaina de Mielina/química , Proteínas Nucleares/química , Proteínas Nucleares/genética , Oligodendroglía/química , Oligodendroglía/fisiología , Nervio Óptico/citología , Estructura Terciaria de Proteína , ARN Mensajero/análisis , Ratas , Ratas Wistar , Activación Transcripcional/efectos de los fármacos

RESUMEN

This paper presents some initial results from the Instituto Tecnológico Geominero de España's (ITGE) study of the Aznalcóllar mine spill. The spatial distribution of the pyritic sludge released was surveyed by using remote sensing data, aerial photography, and more than 700 field measurements on the sludge thickness. Initial estimation of the extent of the sludge was provided by radar data. Maps at 1:10,000 scale, drawn on the basis of field data and interpretation of aerial photos, show the distribution of the sludge, divided into 168 subsections on the basis of average thickness. GIS analysis provided estimates of the area and volume of the sludge. Three approaches were followed in order to survey the effects of the spill on the Guadiamar river alluvial soils: (1) Mineralogical and chemical characterization of the sludge and its evolution until its removal. Alteration products of the pyritic sludge were also analyzed. (2) Determination of geochemical background of soils in the Guadiamar river basin, in order to establish the content of heavy metals and other elements in the soil before the spill. (3) Assessment of the sludge effect on soils caused by the acid water and the deposited sludge, by comparison of the heavy metal content of soil under the sludge layer with that of background soil. Finally, an airborne multispectral survey was carried out over the Aznalcóllar-Doñana area to evaluate its efficiency for monitoring soil condition during and after sludge removal.

Asunto(s)

Accidentes de Trabajo , Hierro , Minería , Contaminantes del Suelo/análisis , Sulfuros , Geografía , Fotograbar , Aguas del Alcantarillado , España

RESUMEN

v-ErbA, a mutated thyroid hormone receptor alpha (TRalpha), is thought to contribute to avian erythroblastosis virus (AEV)-induced leukemic transformation by constitutively repressing transcription of target genes. However, the binding of v-ErbA or any unliganded nuclear receptor to a chromatin-embedded response element as well as the role of the N-CoR-SMRT-HDAC co-repressor complex in mediating repression remain hypothetical. Here we identify a v-ErbA-response element, VRE, in an intronic DNase I hypersensitive site (HS2) of the chicken erythroid carbonic anhydrase II (CAII) gene. In vivo footprinting shows that v-ErbA is constitutively bound to this HS2-VRE in transformed, undifferentiated erythroblasts along with other transcription factors like GATA-1. Transfection assays show that the repressed HS2 region can be turned into a potent enhancer in v-ErbA-expressing cells by mutation of the VRE. Differentiation of transformed cells alleviates v-ErbA binding concomitant with activation of CAII transcription. Co-expression of a gag-TRalpha fusion protein in AEV-transformed cells and addition of ligand derepresses CAII transcription. Treatment of transformed cells with the histone deacetylase inhibitor, trichostatin A, derepresses the endogenous, chromatin-embedded CAII gene, while a transfected HS2-enhancer construct remains repressed. Taken together, our data suggest that v-ErbA prevents CAII activation by 'neutralizing' in cis the activity of erythroid transcription factors.

Asunto(s)

Anhidrasas Carbónicas/genética , Transformación Celular Neoplásica , Leucemia/genética , Proteínas Oncogénicas v-erbA/metabolismo , Elementos de Respuesta , Alpharetrovirus , Animales , Secuencia de Bases , Anhidrasas Carbónicas/biosíntesis , Diferenciación Celular , Huella de ADN , Elementos de Facilitación Genéticos , Eritropoyesis , Regulación Neoplásica de la Expresión Génica , Inhibidores de Histona Desacetilasas , Ácidos Hidroxámicos/farmacología , Intrones , Datos de Secuencia Molecular , Unión Proteica , Receptores de Hormona Tiroidea/metabolismo

RESUMEN

In non-pituitary HeLa cells the unliganded thyroid hormone or retinoic acid receptors cause a strong activation of the rat growth hormone promoter that is repressed by their ligands. In contrast, after expression of the pituitary-specific transcription factor GHF-1, thyroid hormone and retinoic acid produce a stimulation similar to that found in pituitary cells. Therefore, GHF-1 changes a ligand-dependent inhibition into a ligand-dependent activation. The essential role of GHF-1 on the rat growth hormone promoter was also demonstrated with AF-2-defective T3 receptor mutants that show a normal activation of this promoter in the presence of GHF-1. Furthermore, a truncated T3 receptor, which lacks the N-terminus and the DNA binding domain, was able to stimulate this promoter in the presence of GHF-1 and exogenous RXR receptors, suggesting the importance of protein to protein interactions in this regulation. This study shows that the final transcriptional effect depends not only on the type of regulatory promoter response elements but also on the presence of other transcriptional activators, in the case of the growth hormone promoter, the tissue-specific transcription factor GHF-1, which plays a coactivator-like role in this promoter.

Asunto(s)

Proteínas de Unión al ADN/metabolismo , Hormona del Crecimiento/genética , Receptores de Ácido Retinoico/metabolismo , Receptores de Hormona Tiroidea/metabolismo , Factores de Transcripción/metabolismo , Triyodotironina/metabolismo , Animales , Regulación de la Expresión Génica , Hormona del Crecimiento/biosíntesis , Células HeLa , Humanos , Ligandos , Mutación , Fragmentos de Péptidos/metabolismo , Regiones Promotoras Genéticas , Ratas , Receptores de Hormona Tiroidea/genética , Proteínas Recombinantes/metabolismo , Receptores X Retinoide , Factor de Transcripción Pit-1

RESUMEN

The effects of retinoids on gene regulation are mediated by retinoic acid receptors (RARs) and retinoid X receptors (RXRs). Here, we provide the first biochemical evidence that, in vitro, ligand governs the transcriptional activity of RXR alpha/RAR alpha by inducing conformational changes in the ligand-binding domains. Using limited proteolytic digestion we show that binding of the cognate ligand causes a conformational change in the carboxy-terminal part of the receptor. We also show that recombinant RXR alpha/RAR alpha is partially active in the absence of exogenously added ligand. Trans-activation depends critically on the ligand-dependent transcriptional activation function AF-2 of RAR alpha. Full activation by recombinant RXR alpha/RAR alpha, however, requires the addition of either all-trans RA, 9-cis RA, or other RAR-specific agonists, whereas an RAR alpha-specific antagonist abolishes trans-activation. Intriguingly, the ligand-dependent AF-2 of RXR does not contribute to the level of transcription from the RAR beta 2 promoter in vitro even when the cognate ligand (9-cis RA) is bound. Thus, the major role of RXR in trans-activation of the RAR beta 2 promoter is to serve as an auxiliary factor required for the binding of RAR which, in turn, is directly responsible for transcriptional activity.

Asunto(s)

Regulación de la Expresión Génica/efectos de los fármacos , Receptores de Ácido Retinoico/biosíntesis , Retinoides/farmacología , Factores de Transcripción/biosíntesis , Transcripción Genética/efectos de los fármacos , Secuencia de Bases , Línea Celular , Núcleo Celular/metabolismo , Cromatografía de Afinidad , Vectores Genéticos , Células HeLa , Humanos , Datos de Secuencia Molecular , Proteínas Nucleares/biosíntesis , Oligodesoxirribonucleótidos , Regiones Promotoras Genéticas/efectos de los fármacos , Conformación Proteica/efectos de los fármacos , Receptores de Ácido Retinoico/química , Receptores de Ácido Retinoico/aislamiento & purificación , Proteínas Recombinantes de Fusión/biosíntesis , Proteínas Recombinantes de Fusión/química , Proteínas Recombinantes de Fusión/aislamiento & purificación , Receptores X Retinoide , Factores de Transcripción/química , Factores de Transcripción/aislamiento & purificación , Activación Transcripcional , Transfección , Tretinoina/farmacología , Virus Vaccinia

RESUMEN

Transcriptional activation by nuclear receptors is achieved through autonomous activation functions (AFs), a constitutive N-terminal AF-1 and a C-terminal, ligand-dependent AF-2 that comprises a motif conserved between nuclear receptors. We have performed an extensive mutational analysis of the putative AF-2 domain of chicken thyroid hormone receptor alpha (cT3R alpha). We show that the AF-2 region mediates transactivation as well as transcriptional interference (squelching), not only between the thyroid hormone and vitamin (type II) receptors, but also between type II and steroid hormone (type I) receptors. Transcriptional activation and interference require equivalent doses of the cognate ligand, and mutations in the conserved motif that reduce ligand-induced transactivation also impair transcriptional interference. When fused to the Gal4 DNA binding domain, a 35 amino acid long fragment containing the conserved motif is able to transactivate and squelch, albeit in a ligand-independent manner. Our results define the AF-2 of cT3R alpha as an autonomous transactivation domain that, in its natural context, is governed by ligand. We propose that AF-2 is probably part of a surface for interaction with either a general transcription factor or a putative bridging factor, that might be utilized by type I and II receptors.

Asunto(s)

Receptores de Hormona Tiroidea/metabolismo , Transactivadores/metabolismo , Triyodotironina/metabolismo , Secuencia de Aminoácidos , Animales , Sitios de Unión , Línea Celular , Pollos , Secuencia Conservada , Ligandos , Datos de Secuencia Molecular , Mutación , Regiones Promotoras Genéticas , Receptores de Hormona Tiroidea/genética , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/metabolismo , Homología de Secuencia de Aminoácido , Transactivadores/genética , Transcripción Genética

Asunto(s)

Mutagénesis Sitio-Dirigida , Reacción en Cadena de la Polimerasa/métodos , Secuencia de Bases , Cartilla de ADN/química , Datos de Secuencia Molecular

RESUMEN

V-erbA is thought to be an antagonist of thyroid hormone receptor (T3R) function. Here we show that unliganded T3R, but not v-erbA, suppresses retinoic acid (RA)-dependent induction of the RAR-beta 2 promoter by competing for the common dimerization partner, the retinoid X receptor (RXR). Firstly, T3R suppression can be alleviated by co-transfection of RXR. Secondly, T3R, but not v-erbA, competes with RAR for RXR and causes the dissociation of a preformed RAR/RXR-RARE ternary complex in vitro. A single point mutation located in the dimerization interface of v-erbA (Pro349 to Ser) abolishes the transdominant phenotype when introduced at the respective position in T3R. The hypertransforming v-erbA variant r12, in which this mutation is reversed (Ser349 to Pro) suppresses RA-induced differentiation in chicken erythroid progenitors, while v-erbA does not. Our data thus suggest that unliganded T3R and v-erbA act as dominant suppressors through mechanistically distinct pathways.

Asunto(s)

Proteínas Portadoras/metabolismo , Receptores de Superficie Celular/metabolismo , Receptores de Hormona Tiroidea/metabolismo , Proteínas Oncogénicas de Retroviridae/metabolismo , Factores de Transcripción , Activación Transcripcional , Secuencia de Bases , Unión Competitiva , Anhidrasas Carbónicas/genética , Diferenciación Celular , Análisis Mutacional de ADN , Proteínas de Unión al ADN/metabolismo , Eritroblastos/citología , Regulación de la Expresión Génica , Técnicas In Vitro , Ligandos , Datos de Secuencia Molecular , Mutación , Proteínas Oncogénicas v-erbA , Receptores de Ácido Retinoico , Proteínas Recombinantes de Fusión/metabolismo , Secuencias Reguladoras de Ácidos Nucleicos , Receptores X Retinoide , Proteínas Oncogénicas de Retroviridae/genética , Células Tumorales Cultivadas

RESUMEN

In embryonal carcinoma (EC) cells retinoic acid (RA) strongly induces transcription from the RA receptor beta 2 (RAR beta 2) promoter through an RA response element (RARE) located in close proximity to the TATA box. Here we demonstrate that recombinant human TATA box-binding protein, hTFIID, and RAR functionally cooperate in transactivation of the RAR beta 2 promoter in EC cells in a strictly RA-dependent manner. We demonstrate that the core domain of hTFIID is sufficient to mediate RAR-dependent transcription and that Drosophila, but not yeast, TFIID can substitute for hTFIID. In COS cells ectopic expression of the E1A protein is a prerequisite for hTFIID and RAR to cooperate in transactivation. We propose a model for transcriptional regulation of the RAR beta 2 promoter in EC cells in which RAR, following activation by RA, functionally interacts with hTFIID via an E1A-like activity present in EC cells.

Asunto(s)

Proteínas Portadoras/fisiología , Factores de Transcripción/fisiología , Activación Transcripcional , Proteínas Precoces de Adenovirus , Animales , Secuencia de Bases , Sitios de Unión , Línea Celular , Chlorocebus aethiops , Análisis Mutacional de ADN , Drosophila melanogaster/fisiología , Regulación de la Expresión Génica , Humanos , Técnicas In Vitro , Datos de Secuencia Molecular , Proteínas Oncogénicas Virales/fisiología , Regiones Promotoras Genéticas , Receptores de Ácido Retinoico , Secuencias Reguladoras de Ácidos Nucleicos , Saccharomyces cerevisiae , Especificidad de la Especie , Factor de Transcripción TFIID

RESUMEN

Gene regulation by steroid hormones leads to induction or repression of particular sets of genes. These effects are mediated by intracellular hormone receptors that, in the unliganded state, are maintained in an inactive form by unknown mechanisms possibly involving association with other cellular proteins. Induction of the mouse mammary tumor virus (MMTV) requires binding of the hormone receptor to a complex hormone-responsive element (HRE) located between 75 and 190 bp upstream from the start of transcription. The interaction of several receptor molecules with the four receptor binding sites in the HRE is highly cooperative on circular DNA molecules and each individual site is needed for optimal induction. In chromatin the HRE is precisely organized in phased nucleosomes. Following hormone treatment and receptor binding, changes in chromatin structure are detected that correlate with binding of transcription factors, including nuclear factor I, to the MMTV promoter. However, though nuclear factor I acts as a basal transcription factor on the MMTV promoter it does not cooperate with the hormone receptors in terms of binding to free DNA, and mutation of the nuclear factor I binding site does not eliminate hormonal stimulation. This residual induction is mediated by octamer motifs, upstream of the TATA box, that bind the ubiquitous transcription factor OTF-1. Mutation of these octamer motifs does not influence basal transcription in vitro, but completely abolishes the stimulatory effect of progesterone receptor.

Asunto(s)

Proteínas de Unión al ADN/metabolismo , Regulación de la Expresión Génica , Hormonas/farmacología , Receptores de Esteroides/metabolismo , Secuencias Reguladoras de Ácidos Nucleicos , Esteroides/farmacología , Transcripción Genética , Secuencia de Aminoácidos , Animales , Humanos , Virus del Tumor Mamario del Ratón/genética , Modelos Estructurales , Datos de Secuencia Molecular , Conformación de Ácido Nucleico , Conformación Proteica , Transcripción Genética/efectos de los fármacos

RESUMEN

Transcription of telomeric-associated sequences has been detected in the salivary gland cells of the larvae Chironomus thummi. In this species, a heat shock induces puffing at some telomeres, especially at one of the telomeres of chromosome III. We found that this process was concomitant with an increase in the overall telomeric transcript levels. Transcription was also observed in all the telomeres under control conditions, by in situ hybridization, even when these telomeres appeared to be in a nonpuffed state. The telomeric transcripts were found in both, the nuclei and, at higher levels, in the cytoplasmic extracts of salivary gland cells. The heat-shock activation, however, appeared to be restricted to the nuclear level. Telomeric transcription and the peculiar behavior of C. thummi telomeres after a heat shock are discussed.

Asunto(s)

Chironomidae/genética , Cromosomas/fisiología , Transcripción Genética , Animales , Northern Blotting , Núcleo Celular/fisiología , Cromosomas/ultraestructura , Citoplasma/fisiología , Calor , Larva , Hibridación de Ácido Nucleico , ARN/genética , ARN/aislamiento & purificación , Glándulas Salivales/fisiología , Glándulas Salivales/ultraestructura

Asunto(s)

Regulación de la Expresión Génica , Nucleosomas/química , Animales , Secuencia de Bases , Datos de Secuencia Molecular , Nucleosomas/metabolismo